2023 Q2 Form 10-Q Financial Statement

#000143774923012797 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $441.1M $451.1M
YoY Change -4.31% 19.42%
Cost Of Revenue $193.5M $192.3M
YoY Change 1.79% 21.06%
Gross Profit $247.7M $258.8M
YoY Change -8.59% 18.23%
Gross Profit Margin 56.15% 57.37%
Selling, General & Admin $71.66M $70.80M
YoY Change 1.41% 5.42%
% of Gross Profit 28.93% 27.36%
Research & Development $63.69M $63.71M
YoY Change 11.48% 17.75%
% of Gross Profit 25.71% 24.62%
Depreciation & Amortization $9.953M $9.987M
YoY Change 4.11% 9.57%
% of Gross Profit 4.02% 3.86%
Operating Expenses $135.4M $134.5M
YoY Change 4.86% 9.58%
Operating Profit $112.3M $124.3M
YoY Change -20.84% 29.27%
Interest Expense $6.543M $4.808M
YoY Change 96.31% 38.92%
% of Operating Profit 5.83% 3.87%
Other Income/Expense, Net $6.543M $5.297M
YoY Change -228.5% -935.49%
Pretax Income $118.9M $129.6M
YoY Change -13.11% 35.68%
Income Tax $19.36M $19.80M
% Of Pretax Income 16.29% 15.28%
Net Earnings $99.50M $109.8M
YoY Change -13.23% 38.0%
Net Earnings / Revenue 22.56% 24.34%
Basic Earnings Per Share $2.10 $2.32
Diluted Earnings Per Share $2.04 $2.26
COMMON SHARES
Basic Shares Outstanding 47.42M 47.31M
Diluted Shares Outstanding 48.76M 48.66M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $940.5M $917.6M
YoY Change 15.84% 18.62%
Cash & Equivalents $507.0M $489.0M
Short-Term Investments $433.5M $428.6M
Other Short-Term Assets $95.25M $89.96M
YoY Change 171.72% 112.83%
Inventory $427.4M $430.8M
Prepaid Expenses $15.44M $9.719M
Receivables $169.2M $184.3M
Other Receivables $22.19M $19.53M
Total Short-Term Assets $1.632B $1.623B
YoY Change 22.54% 30.11%
LONG-TERM ASSETS
Property, Plant & Equipment $341.9M $354.3M
YoY Change -4.14% -4.08%
Goodwill $6.571M $6.571M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $204.0M $207.6M
YoY Change 207.35% 205.01%
Total Long-Term Assets $588.3M $604.0M
YoY Change 29.69% 29.38%
TOTAL ASSETS
Total Short-Term Assets $1.632B $1.623B
Total Long-Term Assets $588.3M $604.0M
Total Assets $2.221B $2.227B
YoY Change 24.36% 29.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $70.61M $58.00M
YoY Change -9.38% -18.96%
Accrued Expenses $113.4M $156.0M
YoY Change 24.18% 40.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $250.8M $315.8M
YoY Change -1.43% 15.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $76.66M $77.65M
YoY Change 26.22% 18.44%
Total Long-Term Liabilities $76.66M $77.65M
YoY Change 26.22% 18.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $250.8M $315.8M
Total Long-Term Liabilities $76.66M $77.65M
Total Liabilities $381.5M $450.4M
YoY Change 5.23% 16.12%
SHAREHOLDERS EQUITY
Retained Earnings $827.4M $777.1M
YoY Change 51.55% 66.1%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.839B $1.776B
YoY Change
Total Liabilities & Shareholders Equity $2.221B $2.227B
YoY Change 24.36% 29.91%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $99.50M $109.8M
YoY Change -13.23% 38.0%
Depreciation, Depletion And Amortization $9.953M $9.987M
YoY Change 4.11% 9.57%
Cash From Operating Activities $90.19M $218.8M
YoY Change -14.3% 103.69%
INVESTING ACTIVITIES
Capital Expenditures $7.827M $8.854M
YoY Change -166.08% -67.06%
Acquisitions $0.00
YoY Change
Other Investing Activities -$4.224M $21.17M
YoY Change -114.02% 38.68%
Cash From Investing Activities -$12.05M $12.31M
YoY Change -165.92% -206.04%
FINANCING ACTIVITIES
Cash Dividend Paid $36.73M
YoY Change 27.41%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -49.95M -$32.25M
YoY Change 38.3% 33.0%
NET CHANGE
Cash From Operating Activities 90.19M $218.8M
Cash From Investing Activities -12.05M $12.31M
Cash From Financing Activities -49.95M -$32.25M
Net Change In Cash 28.18M $200.4M
YoY Change -67.76% 180.87%
FREE CASH FLOW
Cash From Operating Activities $90.19M $218.8M
Capital Expenditures $7.827M $8.854M
Free Cash Flow $82.36M $210.0M
YoY Change -29.66% 160.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47411000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47411000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47107000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47107000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
311000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
565000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
CY2023Q1 mpwr Lessee Operating Lease Lease Not Yet Commenced Future Lease Obligations
LesseeOperatingLeaseLeaseNotYetCommencedFutureLeaseObligations
0 usd
CY2023Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 usd
CY2022 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17945000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23077000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1776261000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1668602000 usd
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5808 Lake Washington Blvd. NE
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-51026
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0466789
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2226651000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2058885000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451065000 usd
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Kirkland
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98033
CY2023Q1 dei City Area Code
CityAreaCode
425
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
296-9956
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
MPWR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47423000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
488972000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288607000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
428598000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
449266000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
184274000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182714000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
430830000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
447290000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
89955000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
42742000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1622629000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1410619000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
354313000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357157000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
6571000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
6571000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
35571000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
35252000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
207567000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
249286000 usd
CY2023Q1 us-gaap Assets
Assets
2226651000 usd
CY2022Q4 us-gaap Assets
Assets
2058885000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
58001000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
61461000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
101881000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
88260000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155961000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
113679000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
315843000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
263400000 usd
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
56900000 usd
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
53509000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
77647000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
73374000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
450390000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
390283000 usd
CY2023Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
1017131000 usd
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
975276000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
777075000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
716403000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
377714000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
192285000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2786000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39636000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
158834000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
258780000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
218880000 usd
CY2023Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
63709000 usd
CY2022Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
54104000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70795000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68642000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
134504000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
122746000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
124276000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
96134000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5297000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-634000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
129573000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
95500000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19771000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15934000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
109802000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
79566000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.71
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.26
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.65
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47234000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46424000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48655000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48250000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
109802000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
79566000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2919000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-178000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2213000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-5400000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5132000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5578000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
114934000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
73988000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1668602000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
109802000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5132000 usd
CY2023Q1 us-gaap Dividends
Dividends
49130000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1110000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3737000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37008000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1776261000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1243985000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
79566000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5578000 usd
CY2022Q1 us-gaap Dividends
Dividends
36601000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2318000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1326112000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
109802000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
79566000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9987000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189389000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
489095000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9120000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-260000 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1348000 usd
CY2023Q1 mpwr Gain Loss On Deferred Compensation Plan Investments Cash Flow
GainLossOnDeferredCompensationPlanInvestmentsCashFlow
2534000 usd
CY2022Q1 mpwr Gain Loss On Deferred Compensation Plan Investments Cash Flow
GainLossOnDeferredCompensationPlanInvestmentsCashFlow
-2192000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-622000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-381000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
37009000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
39811000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1558000 usd
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
15506000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16063000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51797000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-213000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5916000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-880000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4177000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
13422000 usd
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
27382000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
20137000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
16017000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
17508000 usd
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
9760000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
218807000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
107419000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8854000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26877000 usd
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
129321000 usd
CY2022Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
16243000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
152698000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
32267000 usd
CY2023Q1 mpwr Contributions Made To Deferred Compensation Plan
ContributionsMadeToDeferredCompensationPlan
2209000 usd
CY2022Q1 mpwr Contributions Made To Deferred Compensation Plan
ContributionsMadeToDeferredCompensationPlan
760000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12314000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11613000 usd
CY2023Q1 mpwr Property And Equipment Purchased On Extended Payment Terms
PropertyAndEquipmentPurchasedOnExtendedPaymentTerms
374000 usd
CY2022Q1 mpwr Property And Equipment Purchased On Extended Payment Terms
PropertyAndEquipmentPurchasedOnExtendedPaymentTerms
528000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1110000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2318000 usd
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3737000 usd
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2786000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
36725000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
28825000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-32252000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24249000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1497000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-220000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
200366000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
71337000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
288729000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
260726000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1300000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
244000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2482000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6122000 usd
CY2023Q1 mpwr Dividends And Dividend Equivalents Accrued
DividendsAndDividendEquivalentsAccrued
49219000 usd
CY2022Q1 mpwr Dividends And Dividend Equivalents Accrued
DividendsAndDividendEquivalentsAccrued
36611000 usd
CY2023Q1 mpwr Dividends And Dividend Equivalents
DividendsAndDividendEquivalents
54656000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions used in these condensed consolidated financial statements primarily include those related to revenue recognition, inventory valuation, valuation of share-based awards, contingencies and income tax valuation allowances. Actual results could differ from these estimates and assumptions, and any such differences <em style="font: inherit;"> may </em>be material to the Company’s condensed consolidated financial statements.</p>
CY2023Q1 mpwr Lapse Period For Consignment
LapsePeriodForConsignment
P60D
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
184300000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182700000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3200000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37009000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39811000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
423000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
573000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2659000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
176.50
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
273000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
450.13
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
295000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
217.47
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
9000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
225.18
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2628000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
200.37
CY2023Q1 us-gaap Share Price
SharePrice
500.54
CY2022Q4 mpwr Dividends And Dividend Equivalents
DividendsAndDividendEquivalents
42170000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
19726000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
131367000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
126760000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
126417000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
134071000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
173046000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
186459000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
430830000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
447290000 usd
CY2023Q1 mpwr Prepaid Wafer Purchase Current
PrepaidWaferPurchaseCurrent
50000000 usd
CY2022Q4 mpwr Prepaid Wafer Purchase Current
PrepaidWaferPurchaseCurrent
0 usd
CY2023Q1 mpwr Tax Withholding Share Based Payment Arrangement Proceeds Receivable
TaxWithholdingShareBasedPaymentArrangementProceedsReceivable
15997000 usd
CY2022Q4 mpwr Tax Withholding Share Based Payment Arrangement Proceeds Receivable
TaxWithholdingShareBasedPaymentArrangementProceedsReceivable
14480000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9719000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11045000 usd
CY2023Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
3537000 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
8752000 usd
CY2023Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
10702000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
8465000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
89955000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
42742000 usd
CY2023Q1 mpwr Prepaid Wafer Purchase Current
PrepaidWaferPurchaseCurrent
50000000.0 usd
CY2023Q1 mpwr Prepaid Wafer Purchase Noncurrent
PrepaidWaferPurchaseNoncurrent
120000000 usd
CY2022Q4 mpwr Prepaid Wafer Purchase Noncurrent
PrepaidWaferPurchaseNoncurrent
170000000 usd
CY2023Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
67765000 usd
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
63022000 usd
CY2023Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
19802000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
16264000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
207567000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
249286000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
864000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
932000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
24082000 usd
CY2023Q1 mpwr Stock Rotation Reserve And Accrued Sales Returns
StockRotationReserveAndAccruedSalesReturns
30155000 usd
CY2022Q4 mpwr Stock Rotation Reserve And Accrued Sales Returns
StockRotationReserveAndAccruedSalesReturns
14931000 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
32338000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
15595000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19086000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16901000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155961000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
113679000 usd
CY2023Q1 mpwr Inventory Stock Rotation Reserve
InventoryStockRotationReserve
26400000 usd
CY2022Q4 mpwr Inventory Stock Rotation Reserve
InventoryStockRotationReserve
14300000 usd
CY2023Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
65678000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
64863000 usd
CY2023Q1 mpwr Dividend Equivalents Noncurrent
DividendEquivalentsNoncurrent
6765000 usd
CY2022Q4 mpwr Dividend Equivalents Noncurrent
DividendEquivalentsNoncurrent
6847000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
5204000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
1664000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
77647000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
73374000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
716000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
729000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
538000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
367000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
1254000 usd
CY2022 us-gaap Lease Cost
LeaseCost
1096000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4545000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1010000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
23833000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.034 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.021 pure
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1756000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1591000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1190000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
921000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
929000 usd
CY2023Q1 mpwr Lessee Operating Lease Liability Payments Due Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueThereafter
1509000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7896000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
675000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
500000 usd
CY2022Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
600000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
1112000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
613000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
107000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
20000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1852000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
109802000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
79566000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47234000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46424000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1421000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1826000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48655000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48250000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.71
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.26
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.65
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
19726000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451065000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
377714000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451065000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
377714000 usd
CY2023Q1 us-gaap Noncurrent Assets
NoncurrentAssets
354313000 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
357157000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24082000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
20989000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
362000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
0 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
672000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1380000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-4046000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
4224000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
181774000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
178795000 usd
CY2023Q1 mpwr Prepaid Wafer Purchase Current
PrepaidWaferPurchaseCurrent
50000000.0 usd
CY2023Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
337545000 usd
CY2023Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
337537000 usd
CY2023Q1 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
353952000 usd
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
1029034000 usd
CY2023Q1 us-gaap Cash
Cash
447746000 usd
CY2022Q4 us-gaap Cash
Cash
273145000 usd
CY2023Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
41226000 usd
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
15462000 usd
CY2023Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
131042000 usd
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
130467000 usd
CY2023Q1 us-gaap Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
18163000 usd
CY2022Q4 us-gaap Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
17928000 usd
CY2023Q1 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
35238000 usd
CY2022Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
8285000 usd
CY2023Q1 mpwr Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
919086000 usd
CY2022Q4 mpwr Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
739584000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
488972000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288607000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
428598000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
449266000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
1516000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
1711000 usd
CY2023Q1 mpwr Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
919086000 usd
CY2022Q4 mpwr Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
739584000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
252449000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
249803000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1571000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1516000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
435794000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
430114000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
477020000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
122000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5802000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
471340000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
474643000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
18000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8222000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
466439000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
20962000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
73000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
221666000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
5729000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
242628000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
5802000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
73930000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
975000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
211083000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
7247000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
285013000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
8222000 usd
CY2023Q1 mpwr Redemption Auction Rate Securities To Date
RedemptionAuctionRateSecuritiesToDate
41700000 usd
CY2023Q1 mpwr Percentage Of Auction Rate Securities Redeemedat Par Value
PercentageOfAuctionRateSecuritiesRedeemedatParValue
0.96 pure
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2000000.0 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
5800000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
5400000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
488972000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288607000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
123000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
122000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
489095000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
288729000 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
518454000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
510372000 usd
CY2023Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
67765000 usd
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
63022000 usd
CY2023Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
69869000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
64981000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4808000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3461000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-260000 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1348000 usd
CY2023Q1 mpwr Gain Loss On Deferred Compensation Plan Investments
GainLossOnDeferredCompensationPlanInvestments
2534000 usd
CY2022Q1 mpwr Gain Loss On Deferred Compensation Plan Investments
GainLossOnDeferredCompensationPlanInvestments
-2192000 usd
CY2023Q1 mpwr Gain Loss On Charitable Contribution
GainLossOnCharitableContribution
-2000000 usd
CY2022Q1 mpwr Gain Loss On Charitable Contribution
GainLossOnCharitableContribution
-500000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
215000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-55000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5297000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-634000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19800000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.153 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15900000 usd
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.167 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
47330000 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
34908000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
47300000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
35300000 usd
CY2023Q1 mpwr Accrued Dividend Equivalents
AccruedDividendEquivalents
14100000 usd
CY2022Q4 mpwr Accrued Dividend Equivalents
AccruedDividendEquivalents
13800000 usd

Files In Submission

Name View Source Status
mpwr-20230331_lab.xml Edgar Link unprocessable
0001437749-23-012797-index-headers.html Edgar Link pending
0001437749-23-012797-index.html Edgar Link pending
0001437749-23-012797.txt Edgar Link pending
0001437749-23-012797-xbrl.zip Edgar Link pending
ex_504663.htm Edgar Link pending
ex_504664.htm Edgar Link pending
ex_504665.htm Edgar Link pending
ex_513928.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mpwr-20230331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mpwr-20230331_cal.xml Edgar Link unprocessable
mpwr-20230331_def.xml Edgar Link unprocessable
mpwr20230331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
mpwr-20230331_pre.xml Edgar Link unprocessable
mpwr20230331_10q_htm.xml Edgar Link completed
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending